In addition, seven (88%) of 8 cancers with copy number gains of MAPK15 also had copy number gains of MYC. Therefore, it is possible that gene dosage increase of MAPK15 may be partly influenced by MYC amplification. This evidence concerns the gene MAPK15 and cancer.